Marginal Zone Lymphoma (MZL) Latest Advances

Find the Latest Research About Marginal Zone Lymphoma (MZL)

Last Updated: 02/24/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 1152 publications

Zanubrutinib for the treatment of cutaneous relapse of systemic marginal zone lymphoma: A case report.

Zanubrutinib for the treatment of cutaneous relapse of systemic marginal zone lymphoma: A case report.

Journal: JAAD case reports

Published: January 16, 2026

Rosai-Dorfman disease mimicking testicular malignancy in a patient with marginal zone lymphoma of the lung.

Rosai-Dorfman disease mimicking testicular malignancy in a patient with marginal zone lymphoma of the lung.

Journal: BMJ case reports

Published: January 07, 2026

Secondary cutaneous marginal zone lymphoma arising in association with a Mohs micrographic surgery graft site.

Secondary cutaneous marginal zone lymphoma arising in association with a Mohs micrographic surgery graft site.

Journal: JAAD case reports

Published: December 26, 2025

The guideline for the diagnosis and treatment of marginal zone lymphoma in China (2025)

The guideline for the diagnosis and treatment of marginal zone lymphoma in China (2025)

Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi

Published: December 03, 2025

Nodal Marginal Zone Lymphoma with Prominent Expansion of PD-1+ T-Follicular Helper Cells: A Persistent Diagnostic Challenge with a Heterogeneous Mutational Architecture.

Nodal Marginal Zone Lymphoma with Prominent Expansion of PD-1+ T-Follicular Helper Cells: A Persistent Diagnostic Challenge with a Heterogeneous Mutational Architecture.

Journal: International journal of molecular sciences

Published: November 21, 2025

Ultra low dose radiotherapy for primary ocular adnexal marginal zone lymphoma.

Ultra low dose radiotherapy for primary ocular adnexal marginal zone lymphoma.

Journal: Orbit (Amsterdam, Netherlands)

Published: November 21, 2025

Pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in a common variable immunodeficiency patient.

Pulmonary extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue in a common variable immunodeficiency patient.

Journal: Medicina clinica

Published: November 01, 2025

Mixed type II cryoglobulinemiaassociated glomerulonephritis revealing an extragastric marginal zone lymphoma in the absence of viral infection: A rare case report from Bourges Hospital

Mixed type II cryoglobulinemiaassociated glomerulonephritis revealing an extragastric marginal zone lymphoma in the absence of viral infection: A rare case report from Bourges Hospital

Journal: Nephrologie & therapeutique

Published: October 30, 2025

Efficacy and Safety of Orelabrutinib for Previously Treated Marginal Zone Lymphoma.

Efficacy and Safety of Orelabrutinib for Previously Treated Marginal Zone Lymphoma.

Journal: Journal of hematology

Published: October 28, 2025

Introduction to a review series on marginal zone lymphoma: reclaiming the afterthought.

Introduction to a review series on marginal zone lymphoma: reclaiming the afterthought.

Journal: Blood

Published: October 24, 2025

The Relationship between Ig Class Switch Recombination and MMR Protein, Microsatellite Phenotype in Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue

The Relationship between Ig Class Switch Recombination and MMR Protein, Microsatellite Phenotype in Extranodal Marginal Zone Lymphoma of Mucosa-associated Lymphoid Tissue

Journal: Zhongguo shi yan xue ye xue za zhi

Published: September 11, 2025

Marginal zone lymphoma presenting with chylous ascites: A rare clinical manifestation and successful treatment with orelabrutinib-rituximab.

Marginal zone lymphoma presenting with chylous ascites: A rare clinical manifestation and successful treatment with orelabrutinib-rituximab.

Journal: SAGE open medical case reports

Published: September 11, 2025

Showing 1-12 of 1,152

Last Updated: 02/24/2026